Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology

Vaccinia-based systems have been extensively explored for the development of recombinant vaccines. Herein we describe an innovative vaccinia virus (VACV)-derived vaccine platform technology termed Sementis Copenhagen Vector (SCV), which was rendered multiplication-defective by targeted deletion of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldi, Preethi, Cooper, Tamara H., Liu, Liang, Prow, Natalie A., Diener, Kerrilyn R., Howley, Paul M., Suhrbier, Andreas, Hayball, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628773/
https://www.ncbi.nlm.nih.gov/pubmed/28720468
http://dx.doi.org/10.1016/j.ymthe.2017.06.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628773/
https://www.ncbi.nlm.nih.gov/pubmed/28720468
http://dx.doi.org/10.1016/j.ymthe.2017.06.017

Ejemplares similares